| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.21 | 0.2 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.2 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |